Heart failure etiology impacts survival of patients with heart failure

International Journal of Cardiology

Volumn 149, Issue 2, 2011, Pages 211-215

  Pecini, Redi ^a   Møller, Daniel Vega ^a   Torp Pedersen, Christian ^a   Hassager, Christian ^a   Køber, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dilated cardiomyopathy; Heart failure; Ischemic heart disease; Mortality; Valvular heart disease

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; SURVIVAL RATE;

EID: 79957522979     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.01.011     Document Type: Article

References (30)

1. M. Davies, F. Hobbs, and R. Davis Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study Lancet 358 2001 439 444 (Pubitemid 32769849)
2. W. Rosamond, K. Flegal, and G. Friday Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 2007 e69-171
3. M.R. Cowie, D.A. Wood, and A.J. Coats Incidence and aetiology of heart failure; a population-based study Eur Heart J 20 1999 421 428 (Pubitemid 29116538)
4. G.M. Felker, R.E. Thompson, and J.M. Hare Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084 (Pubitemid 30207690)
5. K.K. Ho, K.M. Anderson, and W.B. Kannel Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115 (Pubitemid 23195439)
6. M.D. Flather, S. Yusuf, and L. Kober Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group Lancet 355 2000 1575 1581 (Pubitemid 30240501)
7. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
8. M. Packer, A.J. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
9. M. Packer, G.V. Antonopoulos, and J.A. Berlin Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am Heart J 141 2001 899 907 (Pubitemid 32477000)
10. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
11. C. Torp-Pedersen, L. Kober, and J.E. Carlsen A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure Eur J Heart Fail 10 2008 89 95
12. R. Razzetti, F. Pastore, and M. Riunno Haemodynamic and neurohormones release inhibiting effects of a DA2/alpha2 agonist Eur J Heart Fail Suppl 1 2 2000 94
13. J. Berning, J. Rokkedal Nielsen, and J. Launbjerg Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis Cardiology 80 1992 257 266
14. L. Kober, C. Torp-Pedersen, and J. Carlsen An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation Eur Heart J 15 1994 1616 1620
15. F. Gustafsson, C. Torp-Pedersen, and B. Brendorp Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur Heart J 24 2003 863 870 (Pubitemid 36528566)
16. M.J. Likoff, S.L. Chandler, and H.R. Kay Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy Am J Cardiol 59 1987 634 638 (Pubitemid 17047334)
17. K.F. Adams Jr., S.H. Dunlap, and C.A. Sueta Relation between gender, etiology and survival in patients with symptomatic heart failure J Am Coll Cardiol 28 1996 1781 1788 (Pubitemid 26426235)
18. M. Packer, C.M. O'Connor, and J.K. Ghali Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med 335 1996 1107 1114 (Pubitemid 26330964)
19. M. Senni, and M.M. Redfield Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 38 2001 1277 1282 (Pubitemid 33032998)
20. M.J. Lenzen, W.J. Scholte op Reimer, and E. Boersma Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220 (Pubitemid 38891571)
21. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269 (Pubitemid 44088349)
22. T.E. Owan, D.O. Hodge, and R.M. Herges Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259 (Pubitemid 44079340)
23. Y. Matsumura, J. Takata, and H. Kitaoka Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years Circ J 70 2006 376 383
24. L. Kober, C. Torp-Pedersen, and J.E. Carlsen A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group N Engl J Med 333 1995 1670 1676 (Pubitemid 26001955)
25. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
26. L. Grigorian Shamagian, A.V. Roman, and P.M. Ramos Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study J Card Fail 12 2006 128 133 (Pubitemid 43340155)
27. C. Tribouilloy, D. Rusinaru, and L. Leborgne Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure Am J Cardiol 101 2008 639 644 (Pubitemid 351625089)
28. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial Lancet 362 2003 777 781 (Pubitemid 37093918)
29. B.M. Massie, P.E. Carson, and J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150